News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Pulmovant (Roivant) will present topline Phase 2 PHocus results for mosliciguat in PH-ILD at the ERS Congress on Sept 8.
  • Roivant will host an investor call immediately after the ERS presentation to discuss the topline findings.
  • Topline results will affect Pulmovant and respiratory-biotech sector valuations.
  • Star Group offers a yield above 6% and has raised distributions for 14 consecutive years.
  • Star Group generates roughly $56.8M in free cash flow with an enterprise value below $600M.
  • SGU trades at about a 5.2 P/E and ~3.2 EV/EBITDA, framing it as a reversion/value trade for income investors.

Latest Articles

Parsons Selected for $350M Seabed to Space ISR Effort

Parsons Selected for $350M Seabed to Space ISR Effort

Parsons Corporation secured a $350 million IDIQ contract from Naval Information Warfare Center Pacific to provide full lifecycle engineering and technical services for the Seabed to Space Intelligence Surveillance Reconnaissance program. This contract supports development, deployment, and sustainment of ISR systems across maritime, air, land, and s…

SGLY Enters Into Non-Binding Strategic Framework Agreement for Potential 900-Acre South Carolina AI Data Center Campus

SGLY Enters Into Non-Binding Strategic Framework Agreement for Potential 900-Acre South Carolina AI Data Center Campus

SingularityNET (SGLY), a Nasdaq-listed digital infrastructure and high-performance computing company, has entered a non-binding strategic framework agreement with Florence Development LLC to evaluate the potential development of a 900-acre AI computing and data center campus in Florence, South Carolina. The site could initially support approximatel…

Snowflake's Momentum Meets a Stretched Valuation

Snowflake's Momentum Meets a Stretched Valuation

Snowflake is trading at $325.01 with a market capitalization of $112.65 billion. While revenue growth has accelerated to 31.1% and strategic AI partnerships have bolstered bookings, the stock is trading at a forward P/E of 157.3x and a fair-value model places intrinsic value at $251.81 - 22.5% below the current price. Technical indicators show stro…

Coinbase Jumps as Bitcoin Short Squeeze and White House Meeting Fuel Rally

Coinbase Jumps as Bitcoin Short Squeeze and White House Meeting Fuel Rally

Coinbase shares climbed sharply in pre-market trading after a combination of a historic Bitcoin short squeeze and a White House meeting with crypto executives improved the company’s regulatory outlook. The stock rose to $170.96, up 6.7% pre-open, while Bitcoin topped $70,000 and roughly $2.7 billion in crypto short positions were liquidated in 24 h…

Pound Firm as Dollar Weakens After U.S. Treasury Signals Buyback Increase

Pound Firm as Dollar Weakens After U.S. Treasury Signals Buyback Increase

Sterling and the euro climbed after the U.S. Treasury unexpectedly expanded liquidity buyback operations by $2 billion, a move that weighed on the dollar and pushed longer-dated U.S. yields down by roughly 10 basis points. The shift in U.S. bond-market dynamics, rather than any domestic UK developments, powered gains in high-beta currencies as risk…

BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

BioNTech presented new clinical data at the IASLC 2026 World Conference on Lung Cancer demonstrating progress across its lung cancer pipeline, including first global data for the novel pumitamig and elfetabart drozuntecan combination, updated survival results for gotistobart, and advancement in mRNA immunotherapies. The data reinforce BioNTech's le…

Gerdau Shares Slide After Analyst Downgrade and Insider Sales

Gerdau Shares Slide After Analyst Downgrade and Insider Sales

Gerdau SA Pref (GGBR4) fell 5.2% to R$22.94 after opening at R$24.55, pressured by an Itaú BBA downgrade on August 11 and a wave of insider sales between August 10 and August 14. The cut in expectations and concerns about Brazil unit margins, alongside broader sector headwinds, helped drive the stock down toward the R$22–23 range highlighted by sev…